A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors
Clinical trial NCT02422589 · COMPLETED
Trial details
- NCT number
- NCT02422589
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-23
- Primary completion
- 2017-12-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.